Journal
NEUROLOGY
Volume 78, Issue 7, Pages 454-457Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3182477ec0
Keywords
-
Categories
Funding
- NIH [RR026315-02]
- Medtronic, Inc.
- CleveMed
- Davis Phinney Foundation
- Michael J Fox Foundation
- Chiesi Pharmaceuticals Inc
- AFaR-Fatebenefratelli Association for Biomedical Research (Rome)
- Fondazione Neureca Onlus (Milan)
- Netherlands Organization for Scientific Research
- Prinses Beatrix Foundation
- Stichting Internationaal Parkinson Fonds
- Alkemade Keuls fonds
- ZonMw
- BrainGain
- MijnZorgNet
Ask authors/readers for more resources
Objective: To describe the phenotype of levodopa-induced on freezing of gait (FOG) in Parkinson disease (PD). Methods: We present a diagnostic approach to separate on FOG (deterioration during the on state) from other FOG forms. Four patients with PD with suspected on FOG were examined in the off state (>12 hours after last medication intake), on state (peak effect of usual medication), and supra-on state (after intake of at least twice the usual dose). Results: Patients showed clear on FOG, which worsened in a dose-dependent fashion from the on to the supra-on state. Two patients also demonstrated FOG during the off state, of lesser magnitude than during on. In addition, levodopa produced motor blocks in hand and feet movements, while other parkinsonian features improved. None of the patients had cognitive impairment or a predating off FOG. Conclusions: True on FOG exists as a rare phenotype in PD, unassociated with cognitive impairment or a predating off FOG. Distinguishing the different FOG subtypes requires a comprehensive motor assessment in at least 3 medication states. Neurology (R) 2012;78:454-457
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available